Short version: the Insolvency Service has banned Paul Jessup, ex-managing director of Strand Capital SA, from acting as a company director for nine years. Regulators found he misused money from Helvetica Investments Ltd, leaving a big gap in the fund’s accounts. If you follow financial governance or invest in funds, this case shows how director actions can lead to personal bans and bigger losses for investors.
Officials say Jessup took or redirected money from Helvetica Investments Ltd that should have been used for the fund and its investors. That misuse produced a significant shortfall — a gap between what should have been in the fund and what actually was. The Insolvency Service investigated and concluded his actions were serious enough to disqualify him from running or directing companies for nine years. That’s a strong enforcement outcome and sends a clear message to fund managers.
The facts are straightforward: a managing director’s duty is to act for the company and its investors. When funds are moved or spent in ways that harm the company or break those duties, regulators step in. Disqualification stops someone from holding director roles and can also affect professional reputation and future work in finance.
If you invest in funds or hold director roles, there are practical steps to take. First, check the public record: Companies House and the Insolvency Service publish disqualification orders and director details. That lets you confirm whether a manager has restrictions. Second, look closely at fund reporting. Regular, clear accounting and independent audits reduce the chance that problems go unnoticed. If audits are delayed or reports are vague, treat that as a red flag.
For directors: keep clear records and follow duties to the company and its investors. If you’re unsure about a payment or transaction, document decisions and seek independent legal or accounting advice. Disqualification cases often involve poor record-keeping or unclear authorisation of moves in and out of fund accounts.
For creditors and counterparties: a director disqualification can affect recovery options and the path of any insolvency. Follow official notices and communicate with insolvency practitioners handling a case. If you suspect misuse, report it to the regulator handling the company’s affairs — in the UK that would include the Insolvency Service or Companies House depending on the issue.
Finally, this case is a reminder that governance matters. Whether you run a fund, work in pharma business units, or invest in companies, asking simple questions about controls, audits, and director history can protect you from surprises. Stay alert, check records, and act quickly if something looks off.
Paul Jessup, the ex-managing director of Strand Capital SA, has been disqualified from serving as a company director for nine years. The Insolvency Service found him guilty of misusing funds from Helvetica Investments Ltd, leading to a significant financial shortfall and his subsequent disqualification.
Flushing medications pollutes waterways and harms aquatic life. Learn why take-back programs are the safest disposal method, what medications should never be flushed, and how to properly dispose of old pills at home.
A clear guide that breaks down FDA risk‑benefit statements, shows where they appear, how to read numbers, and tips for patients to make informed decisions.
A must-read guide showing the safest and smartest routes to buying Flomax online, choosing reliable pharmacies, avoiding scams, and protecting your health.
Emotional blunting from SSRIs affects up to 60% of users, causing numbness, loss of joy, and detachment. Learn why it happens, who it impacts most, and evidence-based solutions like dose reduction and switching to bupropion.
In my latest blog post, I discussed the crucial role of cycloserine in managing multidrug-resistant tuberculosis (MDR-TB). Cycloserine, an antibiotic, has become increasingly important in the treatment of MDR-TB, especially when other first-line medications are ineffective. This is because it targets the bacteria causing TB in a different way, thus overcoming resistance. However, it's essential to use cycloserine in combination with other antibiotics to ensure maximum effectiveness and minimize the risk of further resistance. Overall, cycloserine plays a vital role in the fight against MDR-TB, and ongoing research is crucial to optimize its use and develop new treatments.